Clinical Trial Update: A Comparative Study of ASP1585 in Chronic Kidney Disease Patients With Hyperphosphatemia on Hemodialysis [Phase 3]

View source ↗

Summary

Phase 3 trial of ASP1585 in chronic kidney disease patients with hyperphosphatemia on hemodialysis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Renal Insufficiency

Drugs mentioned

• ASP1585 (ASP1585)

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Chronic Kidney Disease, Renal Dialysis | Phase 3 | Status: COMPLETED